Quarterly Adjusted EBITDA of $11 million vs. $6 million in 2Q last year

Gross Profit Margin improved to 31% as compared to 29% in 2Q last year

Reiterates 2025 revenue and EBITDA guidance

American Vanguard^® Corporation, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the second quarter ended June 30, 2025.

Financial and Operational Highlights Second Quarter 2025– versus Second Quarter 2024:

Net sales of $129 million v. $128 million;
Adjusted EBITDA¹ of $11 million v. $6 million;
Maintains full-year 2025 EBITDA guidance of $40 million to $44 million;
GAAP EPS of $(0.03) v. ($0.42);
Debt outstanding of $189 million which is $22 million less than last year;
Inventory of $191 million which is $53 million less than last year.

Dak Kaye, CEO of American Vanguard, stated, "We are pleased to see the progress that occurred, as part of our business transformation. Operational improvements in the business led to a substantial improvement in adjusted EBITDA, which increased by more than 80% as compared to last year. In addition to our self-help efforts, the agriculture economy appears to be in the early stages of a recovery. Customer destocking is beginning to subside. Against this backdrop, we were able to increase revenue by approximately 1%, as compared to last year."

Mr. Kaye continued, "We substantially increased our gross profit margin and simultaneously decreased our operating expenses as we executed our business transformation. The increase in our gross profit margin to 31%, compared to 29% last year, was driven by improvements in manufacturing and our procurement processes. We will continue to keep a tight rein on expenses and believe that our improved organization will allow us to elevate our gross profit margin over the coming years."

Chief Financial Officer David Johnson stated, "The company is operating more efficiently, as exhibited by decreased inventory and debt levels. Debt outstanding at the end of the quarter was approximately $189 million, a decrease of $22 million, as compared to last year. During the remainder of the year, we expect to allocate our free cash flow towards debt paydown. Further, our improved sales, inventory and operations planning process (SIOP), has allowed the company to operate with less inventory than in the past. Inventory was $191 million at the end of the quarter, a $53 million decrease, as compared to last year. Finally, we continue to operate the business with lower costs than the prior year. Our operating costs were down $5 million in the second quarter and $8 million year-to-date, excluding transformation expenses, which declined dramatically in both the three- and six-month periods. We expect to continue to control our expenses and drive down inventory over the coming quarters as we look to wring more capital out of the business, in an effort to maximize investor returns."

Mr. Kaye concluded, "I want to reiterate our full year 2025 revenue ($535 million - $545 million) and adjusted EBITDA ($40 - $44 million) targets. This quarter we demonstrated real progress in improving operating leverage while maintaining a strong balance sheet. We continue to believe there is room for further improvement, and I am confident that the investments we have been making, and continue to make, in transforming our business will generate accelerated improvements, particularly in a rising market."

Earnings Conference Call

The company will be hosting an earnings conference call at 5 pm ET on July 31, 2025. The conference call can be accessed through the following link: https://www.webcaster4.com/Webcast/Page/3070/52784

A replay can also be accessed through the company website.

The company plans to post on the Investor Relations section of the company's website a presentation that should be read in connection with this earnings release.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agriculture products company that develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. Over the past 20 years, through product and business acquisitions, the Company has significantly expanded its operations and now has more than 1,000 product registrations worldwide. To learn more about the Company, please reference www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release the matters set forth in this press release include forward-looking statements. These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements often use words such as "believe," "expect," "anticipate," "intend," "estimate," "project," "outlook," "forecast," "target," "trend," "plan," "goal," or other words of comparable meaning or future-tense or conditional verbs such as "may," "will," "should," "would," or "could." These forward-looking statements are based on the current expectations and estimates by the Company's management and are subject to various risks and uncertainties that may cause results to differ from management's current expectations. Such factors include risks detailed from time-to-time in the Company's SEC reports and filings. All forward-looking statements, if any, in this release represent the Company's judgment as of the date of this release. The company disclaims any intent or obligation to update these forward-looking statements

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)

ASSETS	June 30, 2025			December 31, 2024
Current assets:
Cash	$	14,482		$	12,514
Receivables:
Trade, net of allowance for credit losses of $11,378 and $9,190, respectively		169,482			169,743
Other		9,470			4,699
Total receivables, net		178,952			174,442
Inventories		191,497			179,292
Prepaid expenses		9,391			7,615
Income taxes receivable		5,004			5,030
Total current assets		399,326			378,893
Property, plant and equipment, net		56,104			58,169
Operating lease right-of-use assets, net		18,390			19,735
Intangible assets, net of amortization		146,168			150,497
Goodwill		20,805			19,701
Deferred income tax assets		3,429			1,242
Other assets		7,756			8,484
Total assets	$	651,978		$	636,721

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	96,778		$	69,159
Customer prepayments		6,490			52,675
Accrued program costs		79,868			69,449
Accrued expenses and other payables		17,312			31,989
Operating lease liabilities, current		6,302			6,136
Income taxes payable		1,994			2,942
Total current liabilities		208,744			232,350
Long-term debt		189,500			147,332
Operating lease liabilities, long term		12,728			14,339
Deferred income tax liabilities		9,217			7,989
Other liabilities		967			1,601
Total liabilities		421,156			403,611
Commitments and contingent liabilities (Note 13)
Stockholders' equity:
Preferred stock, $0.10 par value per share; authorized 400,000 shares; none issued		—			—
Common stock, $0.10 par value per share; authorized 40,000,000 shares; issued 34,778,423 shares at June 30, 2025 and 34,794,548 shares at December 31, 2024		3,478			3,479
Additional paid-in capital		115,853			114,679
Accumulated other comprehensive loss		(12,879	)		(18,729	)
Retained earnings		195,571			204,882
		302,023			304,311
Less treasury stock at cost, 5,915,182 shares at June 30, 2025 and December 31, 2024		(71,201	)		(71,201	)
Total stockholders' equity		230,822			233,110
Total liabilities and stockholders' equity	$	651,978		$	636,721

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)

	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2025			2024			2025			2024
Net sales	$	129,313		$	128,209		$	245,113		$	263,352
Cost of sales		(88,766	)		(90,446	)		(174,375	)		(183,171	)
Gross profit		40,547			37,763			70,738			80,181
Operating expenses
Selling, general and administrative		(28,757	)		(31,051	)		(55,385	)		(60,520	)
Research, product development and regulatory		(5,803	)		(8,599	)		(11,485	)		(14,305	)
Transformation		(1,621	)		(7,345	)		(3,812	)		(8,497	)
Operating income (loss)		4,366			(9,232	)		56			(3,141	)
Change in fair value of equity investment		—			(125	)		—			513
Interest expense, net		(4,450	)		(3,917	)		(8,215	)		(7,610	)
Loss before provision for income taxes		(84	)		(13,274	)		(8,159	)		(10,238	)
Income tax (expense) benefit		(765	)		1,553			(1,152	)		69
Net loss	$	(849	)	$	(11,721	)	$	(9,311	)	$	(10,169	)
Net loss per common share—basic	$	(0.03	)	$	(0.42	)	$	(0.33	)	$	(0.36	)
Net loss per common share—assuming dilution	$	(0.03	)	$	(0.42	)	$	(0.33	)	$	(0.36	)
Weighted average shares outstanding—basic		28,345			28,024			28,308			27,934
Weighted average shares outstanding—assuming dilution		28,345			28,024			28,308			27,934

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

ANALYSIS OF SALES

(In thousands)

(Unaudited)

For the three months ended June 30:

	2025			2024			Change		% Change
Net sales:
U.S. crop	$	52,674		$	52,289		$	385		1	%
U.S. non-crop		19,585			19,011			574		3	%
Total U.S.		72,259			71,300			959		1	%
International		57,054			56,909			145		0	%
Total net sales	$	129,313		$	128,209		$	1,104		1	%
Total cost of sales		(88,766	)		(90,446	)		1,680		-2	%
Total gross profit	$	40,547		$	37,763		$	2,784		7	%
Total gross margin		31	%		29	%

For the six months ended June 30:

	2025			2024			Change			% Change
Net sales:
U.S. crop	$	110,201		$	119,542		$	(9,341	)		-8	%
U.S. non-crop		34,834			36,787			(1,953	)		-5	%
Total U.S.		145,035			156,329			(11,294	)		-7	%
International		100,078			107,023			(6,945	)		-6	%
Total net sales	$	245,113		$	263,352		$	(18,239	)		-7	%
Total cost of sales	$	(174,375	)	$	(183,171	)	$	8,796			-5	%
Total gross profit	$	70,738		$	80,181		$	(9,443	)		-12	%
Total gross margin		29	%		30	%

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

	For the Six Months Ended June 30,
	2025			2024
Cash flows from operating activities:
Net loss	$	(9,311	)	$	(10,169	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property, plant and equipment and amortization of intangible assets		9,447			10,904
Amortization of other long-term assets		11			194
Amortization and accretion of deferred loan fees and discounted liabilities		569			213
Gain on disposal of property, plant and equipment		(40	)		—
Impairment of assets		134			—
Provision for estimated credit losses		1,999			883
Stock-based compensation		981			2,752
Change in deferred income taxes		(200	)		(276	)
Changes in liabilities for uncertain tax positions or unrecognized tax benefits		(60	)		71
Change in equity investment fair value		—			(513	)
Unrealized foreign currency transaction gains		(855	)		(127	)
Changes in assets and liabilities associated with operations:
Increase in net receivables		(3,293	)		(11,962	)
Increase in inventories		(9,785	)		(27,770	)
Increase in prepaid expenses and other assets		(1,863	)		(3,730	)
Change in income tax receivable/payable, net		(1,024	)		(7,129	)
Decrease in net operating lease liability		(100	)		(66	)
Increase in accounts payable		24,547			34,292
Decrease in customer prepayments		(46,187	)		(53,468	)
Increase in accrued program costs		10,267			18,209
Decrease in other payables and accrued expenses		(15,073	)		(1,665	)
Net cash used in operating activities		(39,836	)		(49,357	)
Cash flows from investing activities:
Capital expenditures		(1,020	)		(4,944	)
Proceeds from disposal of property, plant and equipment		51			75
Intangible assets		(88	)		(1,529	)
Net cash used in investing activities		(1,057	)		(6,398	)
Cash flows from financing activities:
Payments under line of credit agreement		(128,665	)		(110,076	)
Borrowings under line of credit agreement		170,834			175,335
Payment of deferred loan fees		(881	)		—
Net receipt from the issuance of common stock under ESPP		333			430
Net payment for tax withholding on stock-based compensation awards		(142	)		(829	)
Payment of cash dividends		—			(1,670	)
Net cash provided by financing activities		41,479			63,190
Net increase in cash and cash equivalents		586			7,435
Effect of exchange rate changes on cash and cash equivalents		1,382			(902	)
Cash and cash equivalents at beginning of period		12,514			11,416
Cash and cash equivalents at end of period	$	14,482		$	17,949

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(Unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Net (loss) income	$	(849	)	$	(11,721	)	$	(9,311	)	$	(10,169	)
Income tax (benefit) expense		765			(1,553	)		1,152			(69	)
Interest expense, net		4,450			3,917			8,215			7,610
Depreciation and amortization		4,709			5,463			9,458			11,093
Stock compensation		422			748			981			2,752
Dacthal returns		(213	)		—			(429	)		—
Asset impairment		134			—			134			—
Transformation costs & legal reserves		1,621			9,310			3,812			10,462
Adjusted EBITDA²	$	11,039		$	6,164		$	14,012		$	21,679


¹ Adjusted earnings before interest, taxes, depreciation, and amortization. Adjusted EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from adjusted EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company's competitors) may define adjusted EBITDA differently.
² Adjusted earnings before interest, taxes, depreciation, and amortization. Adjusted EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from adjusted EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company's competitors) may define adjusted EBITDA differently.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250731931127/en/

Company Contact

American Vanguard Corporation

Anthony Young, Director of Investor Relations

anthonyy@amvac.com

(949) 221-6119

Investor Representative

Alpha IR Group

Robert Winters

Robert.winters@alpha-ir.com

(929) 266-6315

American Vanguard Reports Second Quarter 2025 Results